Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
This study has been completed.
Study NCT01442779 Information provided by Texas Tech University Health Sciences Center
First Received on September 23, 2009. Last Updated on April 18, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Respiratory Tract Diseases
Lung Diseases
Lung Diseases, Interstitial
Pulmonary Fibrosis
Additional conditions recognized in this trial
Fibrosis
Idiopathic Pulmonary Fibrosis
More general conditions related to this trial
Idiopathic Interstitial Pneumonias
Pathologic Processes
Interventions listed in this trial
Interferon alpha oral lozenge
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferon-alpha
Interferons
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Texas Tech University Health Sciences Center
Amarillo Biosciences, Inc.
Back to top of Main Content
